Healthcare · NYSE/NASDAQ: MDLN
Medline Inc.
Medical Instruments & Supplies
Market Cap $66.51B
Verdict: Average
Quality Scores
Multi-Bagger
62/100
Compounder Quality
74/100
Management Credibility
78/100
Governance
82/100
Cash Flow Quality
88/100
AI Summary
Medline Inc. (MDLN) operates as a dominant force in healthcare manufacturing and distribution, evidenced by its massive $28.43B revenue base. The FY2025 data reveals a company with significant operational scale and strong cash generation capabilities, though it reported a marginal net loss of $7M. This disconnect between a $2.21B operating income and a net loss suggests heavy non-operating expenses, likely stemming from interest costs or tax adjustments related to its private-to-public transition. With $38.48B in assets and $10.74B in equity, the company maintains a substantial footprint in…
Top Opportunities
- Massive revenue scale exceeding $28B
- Strong top-line growth at 10% YoY
- Positive and growing CFO
Top Risks
- Persistent net losses over 3-year period
- Thin operating margins typical of distributors
- High competitive intensity from Cardinal/McKesson
Latest report: Read the annual report summary →
Unlock the full report
Full sections, financial charts, AI chat and PDF export are available with Premium.